/    /  Anne Miermont

Anne Miermont


Anne obtained her PhD in Tumor Biology at the University of Georgetown University in Washington DC, USA in 2009, and trained as a postdoctoral fellow at the National Institutes of Health in Bethesda, USA in anti-MEK resistance mechanisms in pancreatic cancer. Anne joined the Federal Agency for Medicinal and Health Products in Brussels, Belgium in 2014 as a non-clinical assessor. She is particularly involved in the assessment of oncological products, at different stages of drug development, including applications for clinical trials in early phase.

LinkedIn icon LinkedIn Profile

User registration

Reset Password